Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 15, No 2 (2019) Long-Term Outcomes of Pharmacoinvasive Reperfusion Strategy Depending on the Choice of Thrombolytic Agent in ST-Segment Elevation Myocardial Infarction Abstract  similar documents
A. V. Khripun, A. A. Kastanayan, M. V. Malevannyi, Y. V. Kulikovskikh
"... in comparing the efficacy of fibrin-selective and fibrin-non-selective thrombolytics. Aim. To study ..."
 
Vol 2, No 4 (2006) THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak
"... It is reported that the implementation in clinical practice thrombolytic (fibrinolytic) therapy ..."
 
Vol 10, No 5 (2014) EVOLUTION OF THROMBOLYTIC THERAPY IN THE TREATMENT OF MYOCARDIAL INFARCTION Abstract  similar documents
P. G. Kesov, O. M. Reytblat, Z. M. Safiullina, S. V. Shalaev
"... History of thrombolytic therapy is shortly reflected, main trials of various thrombolytics ..."
 
Vol 3, No 5 (2007) THROMBOLYTIC THERAPY OF ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
D. P. Sementsov
"... Importance of thrombolytic therapy for restoration of coronary blood flow in acute myocardial ..."
 
Vol 6, No 6 (2010) TENEKTEPLASE: NEW POSSIBILITIES FOR SYSTEMIC THROMBOLYTIC THERAPY OF ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
N. A. Novikova, A. E. Udovichenko
"... plasminogen activator are presented. Efficacy of thrombolytic therapy and percutaneous coronary interventions ..."
 
Vol 12, No 3 (2016) CLINICAL CASE OF THROMBOLYTIC THERAPY OF RECURRENT ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENT WITH LONG HISTORY OF ISCHEMIC HEART DISEASE Abstract  PDF (Eng)  similar documents
N. T. Vatutin, V. B. Kostogryz, A. I. Kostogryz, O. I. Stolika
"... Presented case report demonstrates the efficacy and safety of hospital use of thrombolytic agent ..."
 
Vol 11, No 6 (2015) Use of pharmacoinvasive approach to the treatment of patients with ST segment elevation acute coronary syndrome: state of the problem Abstract  similar documents
S. R. Gilyarevskiy, M. V. Golshmid, I. M. Kuz'mina
"... are given, as well as the results of clinical trials in which the efficacy of thrombolytic therapy at early ..."
 
Vol 13, No 1 (2017) RESULTS OF HOSPITAL USE OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE IN PATIENTS WITH ST-ELEVATED MYOCARDIAL INFARCTION Abstract  similar documents
V. B. Kostogryz
"... mortality was 6%. Conclusion. Modern thrombolytic drug of recombinant non-immunogenic staphylokinase ..."
 
Vol 12, No 2 (2016) THE RESULTS OF USE OF NEW NATIVE THROMBOLYTIC IN CLINICAL PRACTICE Abstract  similar documents
E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov
"... Aim. To assess the efficacy of thrombolytic Fortelyzin in ST elevation myocardial infarction ..."
 
Vol 8, No 2 (2012) SYNCOPE IN NON-MASSIVE PULMONARY EMBOLISM AS A PREDICTOR OF HIGH-RISK MORTALITY Abstract  similar documents
E. A. Kurakina, D. V. Duplyakov, S. M. Khokhlunov, G. S. Kozupitsa
"... (p=0.017). Patients of group 1 needed in thrombolytic therapy 3 times more often than patients ..."
 
Vol 8, No 5 (2012) CLINICAL RESULTS OF THROMBOLYTIC THERAPY WITH ALTEPLASE AND TENECTEPLASE IN PATIENTS WITH MYOCARDIAL INFARCTION Abstract  similar documents
L. A. Bondarenko, L. E. Rudakova, F. K. Rakhmatullov, T. P. Kostrikova, I. I. Kapustina
"... Aim. To evaluate the clinical results of thrombolytic therapy with thrombolytics (alteplase ..."
 
Vol 13, No 6 (2017) THIOL ISOMERASES – A POSSIBLE TARGET FOR THROMBOSIS CONTROL Abstract  similar documents
I. V. Gribkova, M. V. Davydovskaya
"... in regulating both platelet aggregation and fibrin generation in vivo, the possibility of using PDI ..."
 
Vol 9, No 6 (2013) PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE Abstract  similar documents
P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko
"... improving STEMI prognosis - thrombolytics (21% vs 50%; p<0.05), statins (20% vs 53%; p<0.05), beta-blockers ..."
 
Vol 4, No 4 (2008) INCREASED PLASMA LEVEL OF D-DIMER AS A MARKER OF HIGH ARTERIAL THROMBOSIS RISK Abstract  similar documents
N. V. Furman, N. F. Puchinjan, O. M. Ansimova, P. J. Dovgalevsky
"... -dimer is a product of fibrin degradation and its plasma level reflects intensity of intravascular ..."
 
Vol 12, No 3 (2016) EFFECT OF GENDER DIFFERENCES ON THE EFFICACY AND SAFETY OF REPERFUSION THERAPY OF ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION (DATA OF RETROSPECTIVE SINGLE-CENTER STUDY – HOSPITAL PERIOD) Abstract  PDF (Eng)  similar documents
D. B. Nemik, G. V. Matyushin, A. V. Protopopov, A. V. Shulmin, S. A. Ustyugov
"... : thrombolytic therapy, ST-segment elevation myocardial infarction, percutaneous coronary intervention ..."
 
Vol 14, No 3 (2018) ROLE OF SYNTAX SCORE SCALE IN THE STRATIFICATION OF THE NOSOCOMIAL RISK OF CARDIOVASCULAR COMPLICATIONS AND LETHALITY IN PATIENTS WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
D. B. Nemik, G. V. Matyushin, S. A. Ustyugov
"... баллов). Группа с высоким индексом SYNTAX Score была старше, имела большую долю курящих (46,8% против 36 ..."
 
Vol 11, No 1 (2015) CLINICAL CASE OF RUSSIAN THROMBOLYTIC AGENT FORTELYZIN® USE IN PATIENTS WITH ACUTE CORONARY ARTERY DISEASE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, S. V. Utkina
"... One of the three clinical examples of hospital thrombolysis using Russian thrombolytic agent ..."
 
Vol 1, No 2 (2005) ГОЛОВНАЯ БОЛЬ. ФАРМАКО- И ФОТОТЕРАПИЯ ГОЛОВНОЙ БОЛИ НАПРЯЖЕНИЯ Abstract  similar documents
,
"... ГОЛОВНАЯ БОЛЬ ФАРМАКО- И ФОТОТЕРАПИЯ ГОЛОВНОЙ БОЛИ НАПРЯЖЕНИЯ А. Д. Соловьева, Е. Г.Филатова Cайт: «Боль ..."
 
Vol 11, No 6 (2015) RESULTS OF TREATMENT OF ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: DATA OF A RETROSPECTIVE, SINGLE-CENTER STUDY (IN-HOSPITAL PERIOD) Abstract  similar documents
D. B. Nemick, G. V. Matyushin, A. V. Protopopov, S. A. Ustyugov, A. V. Shulmin
"... myocardial damage and residual stenosis after thrombolytic therapy. COPD did not lead to the increase ..."
 
Vol 11, No 2 (2015) LOW SODIUM DIET: PROS AND CONS Abstract  similar documents
O. M. Drapkina, R. N. Shepel'
"... СОДЕРЖАНИЕМ ПОВАРЕННОЙ СОЛИ: ЗА И ПРОТИВ О.М. Драпкина٭, Р.Н. Шепель Первый Московский государственный ..."
 
Vol 2, No 2 (2006) THE WAYS OF SYMPATHETIC SYSTEM OVERACTIVITY BLOCKING: RILMENIDINE VERSUS ATENOLOL Abstract  similar documents
Y. R. Kasherininov, E. K. Shavarova, A. A. Shavarov, N. V. Vachrameeva, A. N. Krutikov, E. V. Smirnova, A. O. Коnrady, E. V. Shlyakhto
"... : РИЛМЕНИДИН ПРОТИВ АТЕНОЛОЛА Ю.Р. Кашерининов, Е.К. Шаварова, А.А. Шаваров, Н.В. Вахрамеева, А.Н. Крутиков, Е ..."
 
Vol 14, No 4 (2018) Some Aspects of Prehospital Thrombolytic Therapy in the Perm Region Abstract  similar documents
S. A. Naumov, N. S. Karpunina
"... Aim. To study data on prehospital thrombolytic therapy in ST elevation myocardial infarction ..."
 
Vol 7, No 5 (2011) PRE-HOSPITAL THROMBOLYSIS IN KRASNOYARSK: RESULTS OF A RETROSPECTIVE COMPARATIVE STUDY Abstract  similar documents
S. A. Skripkin, A. V. Lolenko, V. V. Radionov, M. V. Man'ko, A. E. Bulak
"... and hospital thrombolysis with alteplase. Material and Methods. Pre-hospital thrombolytic therapy ..."
 
Vol 7, No 6 (2011) DIFFERENCES IN EFFECTIVENESS OF ANTIHYPERTENSIVE THERAPY IN MEN AND WOMEN: LOSARTAN VERSUS ENALAPRIL Abstract  similar documents
E. I. Tarlovskaya, D. A. Suvorova, A. A. Sobolev
"... снижалось на лозартане в сравнении с эналаприлом (на 18,2±5,4% против 15,2±4,3%; р=0,02). У мужчин динамика ..."
 
Vol 5, No 2 (2009) REASONS FOR Β-ADRENOBLOCKER USE IN ARTERIAL HYPERTENSION: ONE MORE TIME ABOUT PRO AND CONTRA Abstract  similar documents
V. I. Makolkin
"... -АДРЕНОБЛОКАТОРОВ ПРИ АРТЕРИАЛЬНОЙ ГИПЕРТОНИИ: ЕЩЕ РАЗ «ЗА» И «ПРОТИВ» В.И. Маколкин* Кафедра факультетской терапии ..."
 
Vol 5, No 6 (2009) PHARMACOEPIDEMIOLOGIC ANALYSIS OF ST-ELEVATION MYOCARDIAL INFARCTION REPERFUSION THERAPY AT SARATOV REGION HOSPITALS OF DIFFERENT TYPES Abstract  PDF (Eng)  similar documents
O. V. Reshetko, N. V. Furman, R. M. Magdeev, Ya. P. Ya.P. Dovgalevskiy
"... Aim. To evaluate the real practice of thrombolytic therapy of patients with ST-elevation ..."
 
Vol 6, No 3 (2010) TREATMENT OF THE ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION AT THE PRE-HOSPITAL CARE Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov
"... , thrombolytic therapy. Rational Pharmacother. Card. 2010;6(3):363-369 *Автор, ответственный за переписку ..."
 
Vol 7, No 6 (2011) PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES Abstract  similar documents
R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova
"... .5%, respectively) and rarer used beta-blockers (50% vs 88.9%, respectively) and thrombolytic therapy (3.7% vs 51 ..."
 
Vol 9, No 6 (2013) THROMBOLYSIS OR PRIMARY PCI FOR MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION? THE STREAM TRIAL (STRATEGIC REPERFUSION EARLY AFTER MYOCARDIAL INFARCTION) Abstract  similar documents
V. A. Sulimov
"... groups: a) primary PCI b) prehospital thrombolytic therapy with bolus tenecteplase (dose decreased ..."
 
Vol 13, No 6 (2017) HEART RATE VARIABILITY, VENTRICULAR LATE POTENTIALS AND HEART RATE TURBULENCE AS INDICATORS OF CORONARY REPERFUSION IN ST SEGMENT ELEVATION MYOCARDIAL INFARCTION Abstract  similar documents
E. A. Shigotarova, E. V. Dushina, V. A. Galimskaya, V. E. Oleynikov
"... . The study included 91 patients who underwent effective thrombolytic therapy (TLT) according to the ECG ..."
 
Vol 7, No 5 (2011) DYNAMICS OF ACUTE CORONARY SYNDROME PATIENT MANAGEMENT IN NONIVASIVE PRIMARY VASCULAR CENTER (ACCORDING TO RECORD AND RECORD-2 REGISTERS) Abstract  similar documents
V. M. Provotorov, I. Shevchenko, R. Islamov
"... and November 2009, respectively. Results. Thrombolytic therapy was performed in 62 patients in 2009 whereas ..."
 
Vol 13, No 1 (2017) CHANGE OF ARRHYTHMIC EVENTS IN ACUTE MYOCARDIAL INFARCTION WITH ST-SEGMENT ELEVATION AFTER PHARMACOINVASIVE REVASCULARIZATION Abstract  similar documents
V. E. Oleynikov, E. A. Shigotarova, A. V. Kulyutsin, E. V. Dushina, J. A. Guskova
"... criteria) thrombolytic therapy (TLT) and the subsequent (after 3-24 hours) percutaneous coronary ..."
 
Vol 8, No 4 (2012) APPROACHES TO INCREASE THE AVAILABILITY AND EFFECTIVENESS OF PRE-HOSPITAL THROMBOLYSIS IN REAL CLINICAL PRACTICE Abstract  similar documents
L. A. Ostroumova, S. V. Shalaev
"... thrombolytic therapy of patients with ST segment elevation acute coronary syndrome (STEACS). Material ..."
 
Vol 10, No 3 (2014) THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS Abstract  similar documents
E. A. Shelest, A. E. Shuganov, L. I. Patrushev, I. N. Bokarev
"... свертывания крови: четвертый фактор тромбоцитов PF4 (ELISA), Д-димер (ELISA), фибрино- литическая активность ..."
 
Vol 11, No 5 (2015) Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction Abstract  similar documents
K. G. Adamyan, L. G. Tunyan, A. L. Chilingaryan
"... наблюдались значимо меньшие индекс максимального объема ЛП (21,3±2,4 против 25,2±3,0 и 28,7±3,6 мл/м2 во 2 и ..."
 
Vol 10, No 6 (2014) PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING Abstract  similar documents
N. V. Shcherbakova, A. I. Ershova, A. A. Suvorova, E. Y. Hlebus, A. N. Meshkov, S. A. Boytsov
"... биомаркерам и какую информацию можно получить при фармако-генетическом тестировании с использованием данных ..."
 
Vol 7, No 4 (2011) VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY Abstract  similar documents
L. A. Haisheva, S. V. Shlyk
"... — 1,4% против 23,7%), а также повышение СРПВ по сосудам эластического типа (13,27±0,53 против 8,37±0 ..."
 
Vol 6, No 1 (2010) PECULIARITIES OF PURINE METABOLISM AND LIPID PEROXIDATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
E. V. Horolets, L. A. Haisheva, S. V. Shlyk, L. I. Katelnitskaya
"... ). To evaluate effects of thrombolytic therapy on purine metabolism and lipid peroxidation. Material and methods ..."
 
Vol 12, No 3 (2016) THE ADVANCED TACTICS OF THE MANAGEMENT OF PATIENTS WITH VENOUS THROMBOEMBOLISM: THE ROLE OF RIVAROXABAN AT VARIOUS STAGES OF TREATMENT Abstract  PDF (Eng)  similar documents
S. R. Gilyarevskiy
"... of the treatment strategy in patients with VTE are considered. The role of thrombolytic therapy is highlighted ..."
 
Vol 8, No 2 (2012) CURRENT TARGET OF ANTIHYPERTENSIVE THERAPY. DATA FROM CLINICAL TRIALS. PART 2 Abstract  similar documents
V. V. Popov, N. A. Bulanov, G. G. Ivanov
"... , альдостерон-синтаза, реналаза, эндотелиновые рецепторы, (про)рениновые рецепторы, вакцины против компонентов ..."
 
Vol 8, No 4 (2012) WARFARIN IN PATIENTS WITH CARDIOEMBOLIC STROKE Abstract  similar documents
E. N. Dankovtseva, S. L. Arkhipov, D. A. Zateyshchikov
"... тромболитической терапии в отличие от содержащего в основном фибрин и тромбоциты (белый тромб). По крайней мере ..."
 
Vol 12, No 6 (2016) THE USE OF ENOXAPARIN IN ACUTE CORONARY SYNDROME Abstract  similar documents
E. A. Smirnova, S. S. Yakushin
"... стенокардии в течение 30 дней по сравнению с НФГ (19,8% против 23,3%; p<0,016) при одинако- вой частоте ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... различались по доле лиц мужского пола (47,8% против 24,9%, соответственно), частоте наличия фибрилляции ..."
 
Vol 13, No 1 (2017) COMPARISON OF EFFECTIVENESS OF ANTIARRHYTHMIC THERAPIES IN POSTOPERATIVE PERIOD OF PULMONARY VEIN OSTIA CATHETER ISOLATION FOR PREVENTION OF EARLY RECURRENCES OF ATRIAL TACHYARRHYTHMIAS IN THE PROOF STUDY Abstract  similar documents
A. V. Tarasov, K. V. Davtyan, S. Yu. Martsevich
"... ,37 медикаментозных кардиоверсий против 13,24±10,77 в группе 1 (р=0,013) и против 11,93±12,02 в группе 3 (р=0,123). В ..."
 
Vol 7, No 2 (2011) NONINVASIVE EVALUATION OF FIBRINOLYTIC TREATMENT EFFICACY IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST SEGMENT ELEVATION Abstract  similar documents
I. I. Shevchenko
"... of the thrombolytic therapy (TLT) efficacy  in patients with acute coronary syndrome (ACS) with ST segment elevation ..."
 
Vol 7, No 1 (2011) RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE Abstract  similar documents
R. Rajan, R. Natarajan, G. Vijayaraghavan
"... эффекта, более продолжительный период полураспа- да, более высокую чувствительность к фибрину и большую ..."
 
Vol 6, No 6 (2010) THERAPY FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION PATIENTS WHO PRESENT LATE OR ARE INELIGIBLE FOR REPERFUSION Abstract  similar documents
M. Cohen, C. Boiangiu, M. Abidi, N. S. Chipigina
"... стрептокиназой или фибрин-специфическим тромболитиком и рандоми- зировали в группы лечения эноксапарином или неф ..."
 
Vol 8, No 6 (2012) THE LIS STUDY (LYUBERTSY STUDY ON MORTALITY RATE IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION). EVALUATION OF DRUG THERAPY. PART 2. INFLUENCE OF PREVIOUS DRUG TREATMENT ON LONG-TERM LIFE PROGNOSIS Abstract  similar documents
S. Yu. Martsevich, M. L. Gynzburg, N. P. Kutishenko, A. D. Deev, V. P. Smirnov, L. U. Drozdova, E. V. Daniels, A. V. Fokina
"... was rather high with the exception of thrombolytics (less than 10%). Thrombolytics, β-blockers ..."
 
Vol 14, No 2 (2018) SINGLE AND MULTIPLE ISCHEMIC BRAIN MICROLESIONS AFTER CAROTID ARTERY STENTING Abstract  similar documents
E. S. Bulgakova, T. V. Tvorogova, В. A. Rudenko, O. М. Drapkina
"... (67,0 [64,0, 77,0] против 64,0 [60,0; 70,0], p<0,05), более низкому исходному уровню гемоглобина (130 ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... сред- нем 1172,01 руб. в расчёте на одного пациента против 53,63 руб. при использовании варфарина (p<0 ..."
 
Vol 1, No 2 (2005) MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION IN PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION Abstract  similar documents
F. Van de Werf, D. Ardissino, A. Betriu, D. Cokkinos, E. Falk, K. Fox, D. Julian, M. Lengyel, F.J. Neumann, W. Ruzyllo, C. Thygesen, R. Underwood, A. Vahanian, F. Verheugt, W. Wijns
"... образуется фибрин, вызывающий стаби- лизацию хрупких тромбоцитарных тромбов [6]. Та- ким образом, важную роль ..."
 
Vol 13, No 6 (2017) RISK FACTORS OF ARTERIAL HYPERTENSION IN ORGANIZED COHORT OF MALE EMPLOYEES OF THE MACHINE BUILDING PLANT Abstract  similar documents
A. N. Britov, S. A. Tjupaeva, N. A. Eliseeva, A. N. Meshkov, A. D. Deev
"... ,2%). АГ наблюдалась чаще среди лиц без высшего образования (39,2% против 28,3%; р<0,07). Значимые различия ..."
 
Vol 7, No 2 (2011) COST-EFFECTIVENESS EVALUATION OF PREHOSPITAL THROMBOLYSIS WITH TENECTEPLASE Abstract  similar documents
V. V. Omel'yanovskiy, E. V. Derkach, P. M. Khaylov, S. N. Tereshchenko
"... STEMI symptoms onset, and pre-hospital thrombolysis with bolus thrombolytic administration, when PCI ..."
 
Vol 13, No 4 (2017) COMPARATIVE RESULTS OF RECOMBINANT NON-IMMUNOGENIC STAPHYLOKINASE AND TENECTEPLASE USE IN ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IN REAL CLINICAL PRACTICE Abstract  similar documents
E. S. Mazur, R. M. Rabinovich, V. V. Mazur, N. S. Kuznetsova, E. A. Kudryashova, S. V. Veselov, V. V. Bobkov, D. Yu. Platonov
"... Aim. To compare the efficacy and safety of thrombolytic therapy with recombinant non-immunogenic ..."
 
Vol 8, No 1 (2012) CLINICAL AND FUNCTIONAL FEATURES OF PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION Abstract  similar documents
E. S. Mazur, V. V. Mazur, D. Yu. Platonov, D. V. Kileynikov, T. Yu. Timeshova
"... больных ИСАГ был в шесть раз меньше, чем у больных СДАГ (1,00 против 6,36 мм2/мм рт.ст.), а коэффициент ..."
 
Vol 12, No 2 (2016) LEFT VENTRICULAR REMODELING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION WITH AND WITHOUT ST SEGMENT ELEVATION Abstract  similar documents
N. E. Zakirova, Z. A. Kazieva, A. N. Zakirova
"... , зарегистрированы нарушения сократительной функции (фракция выброса 40,2±5,49% против 61,4±3,91% в контроле; p<0 ..."
 
Vol 9, No 3 (2013) INFLUENCE OF ACARBOSE ON POSTPRANDIAL DYSMETABOLISM: RESULTS OF AN OPEN-LABEL RANDOMIZED STUDY Abstract  PDF (Eng)  similar documents
A. Ya. Cherniak, I. M. Petrov, I. V. Medvedeva
"... ,1% против 44,4%), инсулина (14,4% против 24,4%), СРБ (19,9% против 36,6%), ИЛ-6 (25,1% против 41 ..."
 
Vol 12, No 6 (2016) THE PREVALENCE OF ELECTROCARDIOGRAPHIC INDICATORS AMONG MEN AND WOMEN OF OLDER AGES IN THE RUSSIAN FEDERATION Abstract  similar documents
G. A. Muromtseva, A. D. Deev, V. V. Konstantinov, A. A. Shalnova, S. A. Boytsov
"... ). Результаты. На ЭКГ мужчин в сравнении с женщинами чаще регистрируются патологические зубцы Q(QS) (5% против 1 ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... артериальной гипертонии (82,1 против 77%; р<0,05). В 2014-2015 гг. статистически значимо снизилась частота ..."
 
Vol 10, No 5 (2014) THE RATE AND CHARACTERS OF MASKED ARTERIAL HYPERTENSION AND MASKED INEFFECTIVENESS OF HYPERTENSION TREATMENT IN INDUSTRIAL WORKERS ACCORDING TO THE PREVENTIVE EXAMINATION Abstract  similar documents
M. I. Smirnova, E. M. Platonova, A. N. Britov, V. M. Gorbunov, A. D. Deev, Y. N. Koshelyaevskaya
"... измерений и СМАД, имела более высокий индекс массы миокарда левого желудочка (у мужчин 129,0±21,2 против 109 ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... тромбоцитов (50±20% против 31±20%; p<0,0001), улучшение поток-зависимой вазодилатации (16,9±12,6% против 7,9±7 ..."
 
Vol 15, No 3 (2019) Vascular Remodeling Markers in Patients with Essential Arterial Hypertension Depending on Presence of Type 2 Diabetes Mellitus Abstract  similar documents
Yu. A. Danilogorskaya, E. A. Zheleznykh, E. A. Privalova, Yu. N. Belenkov, A. A. Shchendrigina, M. V. Kozhevnikova, G. A. Shakaryants, V. Y. Zektser, A. S. Lishuta, I. S. Ilgisonis
"... более высокий индекс жесткости (11,15 [10,05; 12,35] против 10,15 [8,83; 11,83] м/с; р=0,04) и ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... - вращая фибриноген в фибрин. Прямые ингибиторы тромбина селективно блокируют активность тромби- на ..."
 
Vol 4, No 2 (2008) ANTICOAGULANTS IN THERAPY OF PATIENTS WITH ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION: WHICH DRUG TO BE CHOSEN? Abstract  similar documents
A. L. Komarov, E. P. Panchenko
"... -химическим и фармако- кинетическим свойствам, что обусловлено различной технологией их производства (табл. 2 ..."
 
Vol 8, No 5 (2012) HIGH HEART RATE AS A POTENTIAL RISK FACTOR FOR DEVELOPMENT OF CARDIOVASCULAR DISEASES IN WOMEN WITH RHEUMATOID ARTHRITIS Abstract  similar documents
D. S. Novikova, T. V. Popkova, A. N. Gerasimov, A. V. Volkov, E. L. Nasonov
"... контрольной группы более высокими значениями минимальной (52,3±0,4 против 47,5±0,4; p<0,001) и средней (78,5±0 ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
"... ,3±37,1 против 310,6±13,3 с; p<0,001), так и небиволола (428,6±33,3 против 310,6±13,3 с; p<0 ..."
 
Vol 13, No 1 (2017) THE STUDY "REGISTER OF PATIENTS AFTER ACUTE STROKE (REGION)". PART 2. OUTPATIENT PROSPECTIVE REGISTER OF PATIENTS AFTER ACUTE STROKE (ACCORDING TO THE RESULTS OF THE PILOT PHASE OF THE STUDY) Abstract  PDF (Eng)  similar documents
S. А. Boytsov, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, L. V. Stakhovskaya, A. N. Vorobyev, A. V. Zagrebelnyy, N. P. Kutishenko, A. N. Kozminsky, K. A. Moseichuk, K. G. Pereverzeva, E. A. Pravkina, E. N. Belova, E. V. Kudryashov, A. D. Deev
"... медикаментозной терапии при ОНМК была чаще (р<0,05) в регистре ОНМК-ПО (статины – 46,9% против 11 ..."
 
Vol 11, No 5 (2015) Efficacy of atorvastatin therapy in prevention of postoperative atrial fibrillation in patients with ischemic heart disease Abstract  similar documents
O. A. Rubanenko
"... встречалась среди больных 2 группы (41,3% против 16,9%; р=0,047). Анализ лабораторных показателей выявил ..."
 
Vol 11, No 5 (2015) Features of the in-hospital course of myocardial infarction in patients with glucose metabolism disorders Abstract  similar documents
B. U. Mardanov, M. N. Mamedov, M. N. Korneeva, R. G. Oganov
"... сравнению со 2 группой значимо чаще регистрировали артериальную гипертензию (73,7% против 49%; p<0,05), у ..."
 
Vol 1, No 2 (2005) INFLUENCE OF MENOPAUSE ON BLOOD PRESSURE DIPPING IN WOMEN WITH METABOLIC SYNDROME: A CASE-CONTROL STUDY Abstract  similar documents
D. A. Anichkov, N. A. Shostak
"... женщин в пременопаузе (для систолического АД: 64% против 52%, p=0,288; для диастолического АД: 34% против ..."
 
Vol 8, No 2 (2012) SHIFTWORK AS ONE OF RISK FACTORS OF ARTERIAL HYPERTENSION AND METABOLIC DISORDERS Abstract  similar documents
I. S. Dzherieva, N. I. Volkova, S. I. Rapoport
"... сотрудников со стандартным трудовым графиком (34,4 против 27,4%, соответственно; р<0,01). Также в группах ..."
 
Vol 12, No 4 (2016) Comparative Analysis of All-cause and Cardiovascular Mortality in Moscow and Irkutsk Abstract  PDF (Eng)  similar documents
F. I. Belyalov, I. V. Samorodskaya, S. V. Pogodaeva
"... ниже в Москве по сравнению с Иркутском во всей выборке (697,6 против 1157,8; p<0,00001), у мужчин (904 ..."
 
Vol 15, No 4 (2019) The Vascular Wall State and Microcirculation Parameters in Patients with Controlled and Uncontrolled Arterial Hypertension Abstract  similar documents
V. I. Podzolkov, A. E. Bragina, D. U. Natkina, T. A. Safronova, N. N. Nebieridze, E. V. Podshibyakina
"... ] против 1138 [1028-1279] см/сек; p=0,385), так и частоте превышения нормальных показателей (95% против 92 ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... к запуску механизма образования тромбина и фибрина. Тромбин является очень мощ- ным стимулятором ..."
 
Vol 6, No 5 (2010) THE INVASIVE DENTAL PROCEDURES IN PATIENTS TREATING WITH WARFARIN: POSSIBILITIES AND PROSPECTS FOR SAFETY Abstract  similar documents
T. V. Kozlova, I. M. Makeyeva, V. Y. Doroshina, S. I. Bokareva
"... Antithrombotic and Thrombolytic Therapy, 2008) не поддерживают подобную позицию [10]. Следует принять во внимание ..."
 
Vol 14, No 3 (2018) NEW-ONSET ATRIAL FIBRILLATION IN SETTINGS OF ACUTE CORONARY SYNDROME. CURRENT ISSUES Abstract  similar documents
G. S. Galjautdinov1, I. V. Gorelkin, K. R. Ibragimova, R. R. Sadriev
"... or thrombolytic therapy is accompanied by the onset of AF, on the contrary, when effective patency of coronary ..."
 
Vol 6, No 1 (2010) EFFICACY OF PHYSICAL TRAINING AND ANALYSIS OF LIPID-LOWERING THERAPY IN PATIENTS WITH ISCHEMIC HEART DISEASE AFTER ACUTE CORONARY INCIDENTS Abstract  PDF (Eng)  similar documents
D. M. Aronov, V. B. Krasnitskij, M. G. Bubnova
"... плотности (ХС ЛПНП). В основной группе реже наблюдались кардиоваскулярные события (14% против 28 ..."
 
Vol 12, No 3 (2016) CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY Abstract  PDF (Eng)  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko
"... больными чаще назначались селективные ингибиторы циклооксигеназы-2 (44% против 17%, соответственно, р<0 ..."
 
Vol 12, No 4 (2016) Morphometric changes of the left ventricle and characteristics of peripheral hemodynamics in patients with drug resistant hypertension Abstract  similar documents
R. R. Kushkhova, A. G. Avtandilov
"... ,8 г/м² против 102,5±3,4 г/м² в группе 2 (p<0,05). В 1 группе относительная толщина стенок ЛЖ достигала ..."
 
Vol 13, No 3 (2017) EFFECT OF EPINEPHRINE ADMINISTRATION ON MYOCARDIAL REMODELING IN EXPERIMENTAL STUDY Abstract  similar documents
V. R. Veber, S. V. Zhmailova, M. P. Rubanova, P. M. Gubskaya
"... ,95±0,64 против 6,83±0,30 об% в контроле; р<0,05), так и в ПЖ (4,71±0,55-против 6,09±0,33 об% в контроле ..."
 
Vol 13, No 5 (2017) INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION Abstract  similar documents
E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash
"... бинированная конечная точка 14,2% против 25%; p=0,14). В группе тикагрелора не выявлено значимого увеличения ..."
 
Vol 14, No 1 (2018) NFLUENCE OF CYP4F2*3 ON RESPONSE TO CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
K. B. Mirzaev, O. D. Konova, E. A. Grishina, K. A. Ryzhikova, Zh. A. Sozaeva, D. A. Andreev, M. Y. Gilyarov, D. A. Sychev
"... (PRU>208) и в группе пациентов с нормальным ответом на клопидогрел (PRU<208): 36,8% против 54,8% (р=0 ..."
 
Vol 14, No 6 (2018) Evaluation of Drug Therapy and Adherence to It in Patients after Acute Coronary Syndrome in Real Clinical Practice (Results of One Year Observation) Abstract  PDF (Eng)  similar documents
L. A. Khaisheva, S. E. Glova, V. A. Suroedov, A. S. Samakaev, S. V. Shlyk
"... , значимо чаще возникали госпитализации в связи с нестабильной стенокардией (15,1% против 7,4%; p<0,05), ОИМ ..."
 
Vol 9, No 4 (2013) COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS Abstract  similar documents
V. A. Sulimov, D. A. Napalkov, A. A. Sokolova
"... - щению фибриногена в фибрин, таким образом пред- отвращая образование тромба. Он ингибирует как свободный ..."
 
Vol 15, No 3 (2019) Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery Abstract  similar documents
A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein
"... GG против группы носителей редкой аллели Т в гетерозиготном состоянии составила, соответственно: 47 ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... образование тромби- на и превращение фибриногена в фибрин, может тор- мозить образование тромба. При действии ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... - рактерные скопления с прядями фибрина. Эти скоп- ления с присоединяющимися тромбоцитами вытяну- той формы ..."
 
Vol 9, No 3 (2013) INTEGRATED ASSESSMENT OF STATIN-ASSOCIATED MUSCLE DAMAGE PREDICTORS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
V. I. Petrov, O. N. Smuseva, Yu. V. Solovkina
"... (48,8 против 11,9 мес, р<0,0001) и в более высоких дозах, чем больные без миалгии и/или слабости в ..."
 
Vol 11, No 1 (2015) METABOLIC EFFECTS OF COMBINED ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH TYPE 2 DIABETES Abstract  similar documents
M. E. Statsenko, M. V. Derevyanchenko
"... выраженности ИР, на 22,5% (17,8±1,4 у.е. исходно против 13,8±1,4 у.е. через 12 нед лечения), а также индекс ..."
 
Vol 9, No 4 (2013) EFFECTS OF ATORVASTATIN ON ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETIC PATIENTS WITH DIFFERENT DURATION F THE DISEASE Abstract  PDF (Eng)  similar documents
G. A. Batrak, S. E. Miasoedova, O. I. Kelesh
"... и 6-10 лет (56% против 42% и 35%, соответственно). Пациенты с достижением целевого уровня липидов ..."
 
Vol 5, No 6 (2009) COMPARATIVE EFFICACY OF AMIODARONE AND BISOPROLOL IN TREATMENT OF VENTRICULAR PREMATURE BEATS IN PATIENTS WITH METABOLIC SYNDROME Abstract  similar documents
V. M. Provotorov, M. L. Gluhovsky
"... в эффективности (50% больных, леченных эффективно, против 17,3%, p=0,02). Отмечена также значимая ..."
 
Vol 12, No 2 (2016) COMPARATIVE PHARMACOKINETICS AND EFFECT ON THE HEMODYNAMICS OF ORIGINAL AND GENERIC NEBIVOLOL IN HEALTHY VOLUNTEERS Abstract  similar documents
E. I. Bambysheva, K. V. Isaeva, M. M. Makhinova, D. T. Guranda, V. G. Belolipetskaya
"... значимо не отличались (AUC0-∞ 41,09±46,82 против 47,16±66,58 нг•ч/мл и Т1/2 30,84±10,78 против 29,59±12 ..."
 
Vol 12, No 5 (2016) Treatment Adherence as a New Choice Factor for Optimization of Oral Anticoagulation Therapy in Patients with Atrial Fibrillation and Hemostatic Gene Polymorphisms Abstract  PDF (Eng)  similar documents
Yu. P. Skirdenko, A. V. Shustov, V. V. Zherebilov, N. A. Nikolayev
"... получающими (65,2±19,3% против 68,5±19,1%; Wald-Wolfowitz; р<0,05). При этом по всем исследуемым параметрам ..."
 
Vol 12, No 5 (2016) The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin Abstract  similar documents
I. Yu. Koroleva, I. V. Kolesnichenko, V. P. Nosov, M. V. Zlobin, D. I. Abelevich
"... случае использования варфарина (0 против 8%; р=0,011). Частота осложнений в виде развития малых ..."
 
Vol 13, No 6 (2017) ASSESSMENT OF CHANGES IN QUALITY OF PREHOSPITAL TREATMENT OF PATIENTS WITH ACUTE CORONARY SYNDROME IN THE LAST FEW YEARS: LIS-1 VS LIS-3 REGISTRIES Abstract  similar documents
Yu. V. Semenova, A. V. Zagrebelnyy, N. P. Kutishenko, M. L. Ginzburg, S. Yu. Martsevich
"... этапе пациенты получали основные препараты, влияющие на прогноз ССЗ – антиагреганты (23,2% против 15 ..."
 
Vol 14, No 1 (2018) NEW APPROACHES TO INDIVIDUALIZED CHOICE OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
Ju. P. Skirdenko, N. A. Nikolayev
"... региональных особенностей, и значимо не различается у респондентов без ФП и с ФП (99,2±41,9 против 100,8±38 ..."
 
Vol 13, No 4 (2017) COMPARATIVE ANALYSIS OF THE EFFICACY OF FIXED-DOSE COMBINATIONS OF AMLODIPINE/LISINOPRIL AND BISOPROLOL/HYDROCHLORTHIAZIDE IN PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION COMBINED WITH OBESITY AND OVERWEIGHT Abstract  similar documents
O. D. Ostroumova, A. I. Kochetkov, M. V. Lopukhina
"... группой бисопролол/гидрохлоротиазид отмечено бол́ ьшее снижение среднесуточного пульсовогоАД(-10,8 против ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... гидрофобными связями, благодаря чему становится невозможным превращение фибриногена в фибрин, т.е. блокируется ..."
 
Vol 10, No 2 (2014) RIVAROXABAN IN PATIENTS STABILIZED AFTER A ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION. RESULTS FROM THE ATLAS ACS-2–TIMI-51 TRIAL Abstract  similar documents
J. L. Mega, E. Braunwald, S. A. Murphy, A. N. Plotnikov, P. Burton, R. G. Kiss, A. Parkhomenko, M. Tendera, P. Widimsky, C. M. Gibson
"... ,2% против 0,6%, р<0,001) и внутричерепных кровоизлияний (0,6% против 0,1%, р=0,015) без значительного ..."
 
Vol 6, No 4 (2010) HEART RATE VARIABILITY IN PATIENTS WITH PREVIOUS Q-WAVE MYOCARDIAL INFARCTION IN DIFFERENT TREATMENT SCHEMES IN EARLY POSTINFARCTION PERIOD Abstract  PDF (Eng)  similar documents
A. A. Abdullaev, R. M. Gafurova, U. A. Islamova, I. A. Kadieva, R. G. Khabchabov
"... группе с 223,8±56,2 до 734±90,9 мс2 (p<0,001) против динамики с 217,8±54,3 до 713±88,1 мс2 и с 225,4±49 ..."
 
1 - 100 of 577 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)